Navigation Links
Nephros Reports 2010 First Quarter Financial Results
Date:5/13/2010

>

Forward-looking statements are not guarantees of future performance, are based on assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond Nephros' control. Actual results may differ materially from the expectations contained in the forward-looking statements. Factors that may cause such differences include the risks that Nephros may not be able: (i) to obtain additional funding when needed or on favorable terms; (ii) to continue as a going concern; (iii) to obtain appropriate or necessary governmental approvals to achieve its business plan or effectively market its products; (iv) to have its technologies and products accepted in current or future target markets; (v) to demonstrate in pre-clinical or clinical trials the anticipated efficacy, safety or cost savings of products that appeared promising to Nephros in research or clinical trials; or (vi) to secure or enforce adequate legal protection, including patent protection, for its products. More detailed information about Nephros and the risk factors that may affect the realization of forward-looking statements is set forth in Nephros' filings with the SEC.  Investors and security holders are encouraged to read these documents on the SEC's website at http://www.sec.gov/. Nephros does not undertake to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise except as required by law.


'/>"/>
SOURCE Nephros, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Nephros Signs Development Agreement with STERIS
2. Nephros Signs Canadian Distribution Agreement with Bellco Health Care Inc.
3. Nephros Reports 2009 Third Quarter Financial Results
4. Nephros Completes Pivotal U.S. Clinical Trial for its Hemodiafiltration Products
5. DUSA Pharmaceuticals Reports Notice of Allowance for Key PDT Device Patent
6. China Nepstar Chain Drugstore Reports First Quarter 2010 Results on May 19
7. ChemoCentryx Reports that Traficet-EN Maintains Remission in Crohns Disease at the Digestive Disease Week (DDW) 2010 Conference
8. Fake Pharmacy Licenses, No-Prescription Meds OK with Internet Companies, LegitScript Reports
9. Stimatix GI Reports Encouraging Interim Results
10. Omeros Reports Additional Phase 2 Data Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery
11. Repligen Reports Notice of Allowance of a United States Patent Covering the Use of Uridine to Treat the Symptoms of Bipolar Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... CHICAGO, Ill. , Sept. 22, 2014 /PRNewswire/ ... data from several clinical studies evaluating potential new ... presented at the upcoming 2014 European Society of ... Madrid, Spain . Data being ... evaluating the safety and efficacy of veliparib (ABT-888), ...
(Date:9/22/2014)... DIEGO , Sept. 22, 2014 Arena Pharmaceuticals, ... company is scheduled to present a corporate overview and ... on Friday, September 26, 2014, at 11:30 a.m. Eastern ... Hotel in New York City . ... will be available under the investor relations section of ...
(Date:9/22/2014)... , September 22, 2014 ... Line Development Market by Product (Equipment, Media and Reagents), ... Engineering & Regenerative medicine, Toxicity Testing, Research, Drug ... published by MarketsandMarkets, analyzes and studies the major ... Browse 114 market data tables and 64 ...
Breaking Medicine Technology:AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 2AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 3AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 4Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 2Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 3Cell Line Development Market Worth $3.96 Billion by 2019 2Cell Line Development Market Worth $3.96 Billion by 2019 3Cell Line Development Market Worth $3.96 Billion by 2019 4
... YORK, Jan. 16, 2012 Reportlinker.com announces ... available in its catalogue: , ... http://www.reportlinker.com/p0751763/Global-Diagnostic-Imaging-Market-Trends-and-Outlook.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging ... imaging market, including: , Estimates ...
... 13, 2012  MedAssurant, Inc., a leading provider of ... for Quality Assurance (NCQA) Software Certification of its ... Data and Information Set (HEDIS®) measurement and reporting ... use, QSI is the nation,s most widely used ...
Cached Medicine Technology:Global Diagnostic Imaging Market Trends and Outlook 2MedAssurant Earns 2012 NCQA Software Certification 2
(Date:9/22/2014)... Hamilton, ON (September 22, 2014) McMaster scientists have ... a new class of antibiotics. , Although dozens ... looked at how a certain part of bacteria are ... stopping it. , The discovery is important as ... is making the cures for infections ineffective. The World ...
(Date:9/22/2014)... PA (PRWEB) September 22, 2014 An ... for patients to the problem of side-sleeping. "My lower ... side, so I designed a solution to this problem," ... asleep comfortably than to have your arm 'fall asleep.'" ... on his or her side more comfortably. It avoids ...
(Date:9/22/2014)... approaches to reducing poverty that help children and ... advocates, and foundations. By combining education and training ... jobs that offer a path out of poverty ... these programs aim to improve the life opportunities ... report from the National Center for Children in ...
(Date:9/22/2014)... September 22, 2014. Kessler researchers have published a ... psychoeducational wellness program in people with multiple sclerosis ... mental health, perceived stress, and pain. "Development ... individuals living with MS: Description and outcomes" was ... the International Journal of MS Care ...
(Date:9/22/2014)... Va. (PRWEB) September 22, 2014 ... the nation’s leading nonprofit authority on the ... healthcare information exchange, announced findings from its recent ... Health Plan Identifier (HPID) within electronic transactions adopted ... (HIPAA). WEDI conducted the survey from August 20 ...
Breaking Medicine News(10 mins):Health News:A two-generation lens: Current state policies fail to support families with young children 2Health News:WEDI Announces Survey Results from Unique Health Plan Identifier (HPID) Industry Poll 2Health News:WEDI Announces Survey Results from Unique Health Plan Identifier (HPID) Industry Poll 3
... FRIDAY, July 29 (HealthDay News) -- The brains of ... signs of a brain disease associated with concussions, say ... findings revealed that Bobby Kuntz (of the Toronto Argonauts ... Rough Riders) had chronic traumatic encephalopathy (CTE). Both players ...
... is available in Spanish . Patients suffering ... attacked and pursued, with the particularity that they express them ... Neurology has published the third consecutive work in five ... The first work showed in 2006 that 45% ...
... FRIDAY, July 29 (HealthDay News) -- Developed countries have ... recent years, but a new international study suggests this ... about the availability of increasingly effective treatments and improving ... of World Health Organization (WHO) breast cancer data collected ...
... University of Cincinnati (UC) research on HIV testing at local ... who do not know they are infected with HIV, even ... study is part of a special supplement to the July ... the Centers for Disease Control and Prevention (CDC). The supplement ...
... Neuroscientists at the University of Bristol have received a ... Council (MRC) to continue their research into the pathological ... dementia, affecting around 465,000 people in the UK. ... latest research into how aspects of electrical signalling go ...
... WASHINGTON The U.S. Food and Drug Administration should gather ... replace the 35-year-old 510(k) clearance process for medical devices, says ... 510(k) process lacks the legal basis to be a reliable ... II devices and cannot be transformed into one, concluded the ...
Cached Medicine News:Health News:Concussion Project Finds Disease in Two Autopsied Brains 2Health News:REM sleep behavior disorder is a risk factor for Parkinson's disease 2Health News:Drop in Breast Cancer Death Rates May Not Be Linked to Screening Rates 2Health News:Drop in Breast Cancer Death Rates May Not Be Linked to Screening Rates 3Health News:Study shows missed opportunities for HIV diagnosis in emergency departments 2Health News:Study shows missed opportunities for HIV diagnosis in emergency departments 3Health News:Scientists receive funding boost to further research into disease mechanisms of Alzheimer’s 2Health News:FDA should invest in developing a new regulatory framework to replace flawed 510(k) medical device clearance process 2Health News:FDA should invest in developing a new regulatory framework to replace flawed 510(k) medical device clearance process 3
The MINI-TAG™ instrument systems are indicated for ulnar collateral ligament repair, scapholunate dissolution, flexor avulsions, and carpometa-carpal arthroplasty....
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Low-profile, hand-held instrument....
Medicine Products: